
|Videos|October 23, 2013
The FDA and Compounding Pharmacies
David G. Miller, RPh, discusses the roles of the FDA and state boards of pharmacy in regulating compounding pharmacies.
Advertisement
In this video, shot at the National Community Pharmacists Association 115th Annual Convention in Orlando, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses the roles of the FDA and state boards of pharmacy in regulating compounding pharmacies.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
2
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
3
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
4
Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis
5

















































































































































































































